Informed-money record

LYCA · Lycia Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$338.9M / size unknown

Recent disclosures

25 of 55 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-10-27	10% owner / other VHCP Management III, LLC	bought	$834K	SEC ↗
2026-10-27	10% owner / other Venrock Healthcare Capital Partners III, L.P.	bought	$834K	SEC ↗
2026-10-27	10% owner / other Venrock Healthcare Capital Partners III, L.P.	bought	$226K	SEC ↗
2026-10-27	10% owner / other Venrock Healthcare Capital Partners EG, L.P.	bought	$834K	SEC ↗
2026-10-27	10% owner / other Venrock Healthcare Capital Partners EG, L.P.	bought	$226K

30 more disclosures in the window — the full record, scoring, and track-record evidence are for members.

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals